Company Filing History:
3 out of 15,579 
3 out of 86 
Years Active: 2016-2019
Title: Innovations of Aaron M Lebeau
Introduction
Aaron M Lebeau is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of 3 patents, his work has the potential to impact therapeutic strategies in oncology.
Latest Patents
Lebeau's latest patents focus on antibodies specific for urokinase-type plasminogen activator (uPA). These antibodies are designed to bind specifically to the active form of uPA, which is crucial in cancer treatment. The patents detail methods where the anti-uPA antibody competes for binding with plasminogen activator inhibitor type 1 (PAI-1). This binding leads to the internalization of a complex that includes the antibody, uPA, and urokinase-type plasminogen activator receptor (uPAR). Additionally, the patents provide formulations and methods related to these antibodies, enhancing their application in pharmaceutical settings.
Career Highlights
Lebeau has worked with prestigious institutions such as the University of California and CytomX Therapeutics, Inc. His experience in these organizations has allowed him to collaborate on innovative projects that advance cancer research and treatment.
Collaborations
Some of his notable coworkers include Natalia Sevillano and Daniel Robert Hostetter. Their collaborative efforts have contributed to the success of various research initiatives.
Conclusion
Aaron M Lebeau's work in developing specific antibodies for cancer treatment showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new therapeutic options in oncology.